ASML Holding N.V. (ASML) vs Eli Lilly and Company (LLY)
See how ASML Holding N.V. and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$1,676.69
NasdaqGS
$1,270.75
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full PageKey Metrics Comparison
ASML Holding N.V.ASML
Market Cap$646.226B
Price$1,676.69
24h Change+2.81%
24h Volume$1.24M
Employees44,681
Shares OutstandingN/A
Eli Lilly and CompanyLLY
Market Cap$1.133T
Price$1,270.75
24h Change-1.01%
24h Volume$1.87M
Employees50,000
Shares Outstanding944,818,881
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ASML
36.3%LLY
63.7%Volume Share
Share of combined 24h volume
ASML
39.8%LLY
60.2%24h Performance
Price change over last 24 hours
ASML
2.81%LLY
-1.01%Price Comparison
ASML Holding N.V.
Eli Lilly and Company